Back to Journals » Clinical Epidemiology » Volume 5 » Issue 1

The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)

Total article views   HTML views PDF downloads Totals
18,742 Dovepress* 13,678+ 2,210 15,888
PubMed Central* 5,064 1,072 6,136
Totals 18,742 3,282 22,024
*Since 26 April 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar